It is easy to understand why so many people want something that feels less intimidating, with fewer side effects, and easier to fit into daily life
With over 50% of GLP-1 users discontinuing due to cost and 36% due to side effects, Nooms low and slow titration strategy could offer a more sustainable path to weight loss
10.1186/s12933-017-0646-z 48 LeporeJ
The effectiveness of the treatment is influenced by factors such as a persons starting weight, their metabolism, the dosage of the medication, and their adherence to a healthy diet and regular exercise
AI and AI-assisted tools statement During the preparation of this manuscript, the AI tool OpenAI GPT (version 5.5, released 2026-04-23) was used solely for language editing
Midi is the clear top choice for women in menopause or perimenopause seeking a GLP-1 program that treats weight management as part of a comprehensive hormonal health strategy